Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. GH
GH logo

GH

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GH News

Verana Health Partners with Guardant Health to Enhance Cancer Therapy Development

6d agoPRnewswire

Verana Health Partners with Guardant Health to Enhance Oncology Research

6d agoNewsfilter

Guardant Reveal Expands Cancer Detection Utility in MRD Monitoring

Mar 18 2026Newsfilter

U.S.-Iran Conflict Triggers Volatility in Healthcare Stocks

Mar 16 2026seekingalpha

Guardant Health Partners with Manulife to Launch Multi-Cancer Detection Test in Asia

Mar 16 2026Newsfilter

Survey Reveals Barriers to Colorectal Cancer Screening

Mar 13 2026Newsfilter

Following Grail's Study Setback, What Remains for Cancer Blood Screening?

Feb 26 2026Barron's

U.S. Stocks Rise Following Landmark Supreme Court Ruling

Feb 20 2026NASDAQ.COM

Guardant Health Acquires MetaSight Diagnostics for $59M

Feb 20 2026seekingalpha

GUARDANT HEALTH INC: STIFEL INCREASES TARGET PRICE FROM $120 TO $130

Feb 20 2026moomoo

Stock Market Movers: Opendoor, Nvidia, Grail, Newmont, AppLovin, and Others

Feb 20 2026Barron's

Guardant Health Reports Strong Q4 2025 Earnings with Significant Growth

Feb 20 2026seekingalpha

Latest Ratings and Outlook from Wall Street

Feb 17 2026CNBC

Guardant Health Launches Colorectal Cancer Screening Grant Program

Feb 12 2026PRnewswire

Guardant Health Launches Colorectal Cancer Screening Grant Program

Feb 12 2026Newsfilter

AI Drives Transformation in Genomics and Biological Manufacturing

Feb 10 2026Newsfilter